PT Ikapharmindo Putramas Tbk
IIDX:IKPM160.00
IDR
+5.00
(+3.23%)
ISIN
ID1000199409
Return %
Stock
S&P 500
1Y
-32.77
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Kartono Gunawa
- Full Time Employees
- 1,014
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Jakarta Timur Indonesia
- IPO Date
- Nov 8, 2023
- Website
- ikapharmindo.com
- Similar Companies
- Business
- PT Ikapharmindo Putramas Tbk is an Indonesia-based healthcare company engaged in the development, manufacturing, marketing, and distribution of pharmaceutical formulations, consumer health products, infant and mother care goods, and personal care items. Founded in 1978 and headquartered in East Jakarta, Indonesia, the company operates primarily across four business divisions: Ethical Pharmaceuticals, Consumer Health and Over-the-Counter (OTC) Products, Baby and Child Care, and Contract Manufacturing Services. Its Ethical Pharmaceuticals segment offers prescription medications across multiple therapeutic areas, including central nervous system agents, cardiovascular drugs, dermatological treatments, gastrointestinal remedies, respiratory medicines, antibiotics, and analgesic therapies; its Consumer Health segment supplies specialized over-the-counter products, medicated hair care and anti-dandruff shampoos under the Selsun brand, topical antiseptic creams, vitamins, and wellness supplements; its Baby Care division manufactures and distributes infant and maternal care merchandise, including feeding bottles, nipples, breast pumps, sterilizers, baby toiletries, cleansing wipes, and specialized infant skincare, primarily under the licensed Pigeon brand; and its Contract Manufacturing unit provides formulation development, toll manufacturing, and packaging services to domestic and multinational pharmaceutical and cosmetic enterprises. The company operates manufacturing facilities located in the Pulogadung Industrial Estate in Jakarta and serves retail pharmacies, hospitals, clinics, modern supermarkets, general trade stores, and e-commerce channels across Indonesia, alongside exporting selected product lines across Southeast Asia. In recent developments, PT Ikapharmindo Putramas Tbk completed its initial public offering on the Indonesia Stock Exchange under the ticker IKPM in December 2023, utilizing proceeds to expand production capacity, upgrade cleanroom facilities, and fund working capital; broadened its maternal and baby care portfolio with new product introductions under its licensing agreements; expanded its nationwide distribution infrastructure to increase market penetration across Tier-2 and Tier-3 Indonesian cities; and modernized its semi-solid and liquid pharmaceutical production lines to support expanded third-party contract manufacturing operations.